[{"Assets_0_Q2_USD":9951980000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":1013308000.0,"NetIncomeLossConverted_1_Q2_USD":551412000.0,"NetIncomeLossConverted_2_Q2_USD":1029392000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":114477000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":114697000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":107800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":107724000.0,"StockholdersEquity_0_Q2_USD":7186426000.0,"EarningsPerShareBasic_1_Q2_USD":5.12,"EarningsPerShareBasic_2_Q2_USD":9.56,"EarningsPerShareDiluted_1_Q2_USD":4.82,"EarningsPerShareDiluted_2_Q2_USD":8.97,"RevenuesConverted_1_Q2_USD":1608022000.0,"RevenuesConverted_2_Q2_USD":3119507000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS INC","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20180802"}]